5th Annual Update in Neuro-Oncology
- Continuing Education
Deepen your expertise in neuro-oncology with this expert-led course offering the latest advances in diagnosis, treatment, and management of CNS and PNS tumors and neurological complications of cancer.
On This Page
Overview
Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). The field of neuro-oncology also encompasses neurogenetic syndromes, like neurofibromatosis, associated with nervous system tumors and various neurological complications of cancer and cancer treatments. In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification.
This three-day CME course, the 5th Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors, specific neurogenetic syndromes, and neurological complications of cancer.
The target audience consists of providers and trainees involved in the care of adult and pediatric neuro-oncology patients (neurologists, oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, nurses, and industry professionals.
Learning Objectives
- Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
- Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
- Recognize and manage neurological complications associated with new cancer therapies.
- Describe and manage long-term complications of CNS and PNS tumors and their treatment.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Mass General Brigham, Dana-Farber Cancer Institute, and Boston Children's Hospital.
Participant Types
Schedule
All agenda sessions are in Eastern Time.
Wednesday, July 23, 2025
Opening Remarks: Pediatric Neuro-Oncology Session
10:00-10:10 am
WHO Classification, Pediatric CNS Tumors
10:10-10:40 am
Advances in the Imaging of Pediatric Brain Tumors
10:40-11:10 am
Embryonal Tumors
11:10-11:30 am
Pediatric Low-Grade Gliomas
11:30-11:50 am
Break
11:50 am-12:00 pm
Pediatric High-Grade Gliomas
12:00-12:30 pm
Ependymomas
12:30-12:45 pm
Live Question and Answer Session
12:45-1:15 pm
Break
1:15-1:30 pm
Choroid Plexus Tumors
1:30-1:45 pm
Pineal Tumors
1:45-2:00 pm
Germ Cell Tumors
2:00-2:15 pm
Neurofibromatosis and Schwannomatosis
2:15-2:45 pm
Von Hippel Lindau
2:45-3:00 pm
Live Question and Answer Session
3:00-3:15 pm
Live CNS Tumor Board
3:15-3:45 pm
Ajourn
3:45-3:50 pm
Thursday, July 24, 2025
Welcome: Adult Neuro-Oncology
10:00-10:05 am
Advances in Surgery for Brain Tumors
10:05-10:20 am
Advances in the Imaging of Adult Brain Tumors
10:20-10:35 am
Advances in Radiation for Brain Tumors
10:35-10:50 am
WHO Classification for Adult Gliomas
10:50-11:20 am
Live Question and Answer Session
11:20-11:35 am
Break
11:35 am-12:00 pm
Gliomas, IDH-Mutant
12:00-12:30 pm
Gliomas, IDH-Wildtype
12:30-12:45 pm
Advances in Experimental Therapies for Gliomas
12:45-1:15 pm
Live CNS Tumor Board
1:15-1:45 pm
Break
1:45-2:00 pm
Meningiomas
2:00-2:15 pm
CNS lymphomas
2:15-2:30 pm
Pituitary Tumors
2:30-2:45 pm
Live Question and Answer Session
2:45-3:00 pm
Adjourn
3:00-3:05 pm
Friday, July 25, 2025
Welcome: Neurological Complications of Cancer
10:00-10:05 am
Metastases to the Brain
10:05-10:35 am
Metastases to the Leptomeninges
10:35-10:50 am
Metastases to the Epidural Space and Spinal Cord
10:50-11:05 am
Paraneoplastic Neurological Syndromes
11:05-11:20 am
Live Question and Answer Session
11:20-11:40 am
Break
11:40 am-12:00 pm
Common Neurological Complications in Cancer Patients
12:00-12:30 pm
Neurological Complications of Cancer Immunotherapies
12:30-12:45 pm
Survivorship of CNS tumors
12:45-1:00 pm
Live Question and Answer Session
1:00-1:15 pm
Live CNS Tumor Board
1:15-1:45 pm
Closing Statements
1:45-2:00 pm
Faculty
Tracy Batchelor, MD, MPH
Course Director
- Neurologist-in-Chief and Chair, Department of Neurology, Mass General Brigham
- Martin A. Samuels Professor of Neurology, Harvard Medical School
E. Antonio Chiocca, MD, PhD
Course Director
- Neurosurgeon-in-Chief and Chair, Department of Neurosurgery, Brigham and Women’s Hospital
- Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School
Patrick Wen, MD
Course Director
- Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute
- Professor of Neurology, Harvard Medical School
Sanda Alexandrescu, MD
Associate Professor of Pathology, Harvard Medical School
Isabel Arrillaga-Romany, MD
Assistant Professor of Neurology, Harvard Medical School
Lissa Baird, MD
Member of the Faculty of Neurosurgery, Harvard Medical School
Pratiti Bandopadhayay, MBBS, PhD
Associate Professor of Pediatrics, Harvard Medical School
Viviana Benitez, MD
Instructor in Neurology, Harvard Medical School
Wenya Linda Bi, MD, PhD
Associate Professor of Neurosurgery, Harvard Medical School
Priscilla Brastianos, MD
Associate Professor of Medicine, Harvard Medical School
John H. Chi, MD, MPH
Associate Professor of Neurosurgery, Harvard Medical School
Susan N. Chi, MD
Associate Professor of Pediatrics, Harvard Medical School
Jorg Dietrich, MD, PhD
Associate Professor of Neurology, Harvard Medical School
Lisa M. Doherty, NP
Nurse Practitioner
Mariella Filbin, MD, PhD
Associate Professor of Pediatrics, Harvard Medical School
Deborah Forst, MD
Assistant Professor of Neurology, Harvard Medical School
Galina Gheihman, MD
Member of the Faculty of Neurology, Brigham and Women's Hospital
L. Nicolas Gonzalez Castro, MD, PhD
Assistant Professor of Neurology, Harvard Medical School
David Gritsch, MD, PhD
Clinical Fellow in Neurology, Harvard Medical School
Annie Hsieh, MD, PhD
Instructor in Neurology, Harvard Medical School
Raymond Huang, MD, PhD
Associate Professor of Radiology, Harvard Medical School
Othon Iliopoulos, MD
Associate Professor of Medicine, Harvard Medical School
Pamela S. Jones, MD, MPH
Assistant Professor of Neurosurgery, Harvard Medical School
Justin Jordan, MD, MPH
Associate Professor of Neurology, Harvard Medical School
Shannon MacDonald, MD
Associate Professor of Radiation Oncology, Harvard Medical School
Ariel Marciscano, MD
Member of the Faculty of Medicine, Harvard Medical School
Maria Martinez-Lage Alvarez, MD
Assistant Professor of Pathology, Harvard Medical School
Julie Miller, MD, PhD
Assistant Professor of Neurology, Harvard Medical School
Tina Young Poussaint, MD, FACR
Professor of Radiology, Harvard Medical School
David Reardon, MD
Professor of Medicine, Harvard Medical School
Nancy Wang, MD, MPH
Instructor in Neurology, Harvard Medical School
Karen Wright, MD
Assistant Professor of Pediatrics, Harvard Medical School
Kee Kiat Yeo, MD
Assistant Professor of Pediatrics, Harvard Medical School
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, access to recordings, and power point presentations for 60 days after the course.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
Undergraduate Student Discount of $100 available. Please email okatsovskiy@bwh.harvard.edu to request approval of the Student Discount.
10% discount for organizations registering 5 or more learners.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $800.00 |
| Nurse (RN/APRN) | $600.00 |
| Resident/Fellow | $600.00 |
| Allied Health Professional / Other | $600.00 |
Prorated daily rates are available for those only attending the course partially.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 12.75 ANCC contact hours.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.